MetLife, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $77.08B | $70.99B | $66.91B | $68.77B | $68.70B | $67.84B | $69.62B | $67.94B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $560.0M | $481.0M | $828.0M | $669.0M | $670.0M | $761.0M | $901.0M | $910.0M |
| Operating Income | $6.14B | $6.00B | $5.72B | $5.98B | $9.17B | $7.56B | $7.45B | $7.13B |
| Operating Margin | 8.0% | 8.4% | 8.6% | 8.7% | 13.3% | 11.1% | 10.7% | 10.5% |
| Interest Expense | $724.0M | $738.0M | $740.0M | $655.0M | $647.0M | $632.0M | $656.0M | $827.0M |
| Pretax Income | $4.66B | $5.62B | $2.16B | $6.36B | $8.52B | $6.93B | $6.80B | $6.31B |
| Income Tax Expense | $1.26B | $1.18B | $560.0M | $1.06B | $1.64B | $1.51B | $886.0M | $1.18B |
| Net Income | $3.38B | $4.43B | $1.58B | $5.28B | $6.86B | $5.41B | $5.90B | $5.12B |
| Net Margin | 4.4% | 6.2% | 2.4% | 7.7% | 10.0% | 8.0% | 8.5% | 7.5% |
| EPS (Basic) | $4.74 | $5.98 | $1.82 | $6.35 | $7.71 | $5.72 | $6.10 | $4.95 |
| EPS (Diluted) | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 | $5.68 | $6.06 | $4.91 |
| Shares Outstanding (Basic) | 668.9M | 706.4M | 757.7M | 803.2M | 862.7M | 907.8M | 937.6M | 1.01B |
| Shares Outstanding (Diluted) | 673.3M | 711.1M | 762.3M | 808.9M | 869.4M | 913.2M | 944.4M | 1.01B |
| Dividends Per Share | $2.25 | $2.16 | $2.06 | $1.98 | $1.90 | $1.82 | $1.74 | $1.66 |